Page 11 - New Europharm presentation

Lebanon’s
pharmaceutical market

With more than 50 pharmaceutical importers, Lebanon is the leading market for imported
pharmaceutical drugs in the Levant. The pharmaceutical market in Lebanon is valued at over $1
billion, with potential annual growth of more than five percent. Patented drugs constitute around 50
percent of the market, and over-the-counter (OTC) and generic drugs constitute around 25 percent
each. Lebanon-based pharmaceutical production is weak due to high local production costs. As
a result, imports constitute over 95 percent of the total available pharmaceutical products in the
market.According to the Lebanese Customs Authority, total pharmaceutical imports into Lebanon
reached $1.288 billion in 2017, of which $143 million were imported from the United States. Local
production covers less than five percent of market demand and is mainly focused on manufacturing
drugs under license for international companies.